Published in J Natl Compr Canc Netw on September 01, 2015
Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors. Hum Reprod (2016) 0.78
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. Int J Endocrinol (2016) 0.75
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Oncotarget (2016) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg (2014) 5.18
Clinical practice. The thyroid nodule. N Engl J Med (2004) 4.84
The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg (1998) 4.46
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer (1997) 3.70
Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT): Contents. J ICRU (2010) 3.58
Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med (1994) 3.38
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg (1998) 2.58
[The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)]. Strahlenther Onkol (2012) 2.53
Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer (2005) 2.42
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol (2006) 2.40
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer. Surgery (2012) 2.29
Multimodal approach to anaplastic thyroid cancer. Oncology (Williston Park) (2012) 2.11
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer (2008) 2.10
Risks of complication following thyroidectomy. J Gen Intern Med (1998) 2.07
The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal (2008) 2.05
Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer (1990) 2.01
False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid (2004) 1.93
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab (2012) 1.80
Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid (2010) 1.64
Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab (1997) 1.59
Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol (2011) 1.54
Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54
Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer (1978) 1.45
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid (2010) 1.43
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
BRAF V600E inhibition in anaplastic thyroid cancer. N Engl J Med (2013) 1.38
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer (2001) 1.36
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid (2009) 1.35
Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid (2011) 1.34
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A (2014) 1.32
A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid (2010) 1.26
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Thyroid aspiration cytology: current status. CA Cancer J Clin (2009) 1.20
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid. Thyroid (2013) 1.19
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet (2015) 1.18
Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid (2010) 1.15
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.15
Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer (1987) 1.14
Optimal surgery for papillary thyroid carcinoma. World J Surg (1996) 1.12
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid (1998) 1.11
Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.11
Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol (2008) 1.10
Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol (2011) 1.10
Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients. Radiother Oncol (2009) 1.08
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer (2006) 1.08
Anaplastic thyroid carcinoma: palliation or treatment? Curr Opin Otolaryngol Head Neck Surg (2011) 1.08
Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol (1992) 1.08
State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother (2011) 1.07
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid (2013) 1.07
p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene (1997) 1.05
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head Neck (2010) 1.02
Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid (2013) 1.01
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur J Endocrinol (2007) 1.01
Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer (2011) 1.00
Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope. Curr Opin Oncol (2008) 0.96
Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients. Oncology (2011) 0.94
Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol (2002) 0.93
Identification of a recurrent STRN/ALK fusion in thyroid carcinomas. PLoS One (2014) 0.93
BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. Br J Cancer (2007) 0.92
Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol (2014) 0.92
The role of external beam radiation and targeted therapy in thyroid cancer. Semin Radiat Oncol (2012) 0.89
Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab (1997) 0.89
Conservative management of well-differentiated thyroid cancer. Can J Surg (2010) 0.86
Long-term results of radiotherapy in anaplastic thyroid cancer. Radiat Oncol (2014) 0.86
Airway management in anaplastic thyroid carcinoma. Laryngoscope (2008) 0.86
A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. Am J Surg Pathol (2015) 0.83
Management of anaplastic thyroid cancer. Gland Surg (2015) 0.83
CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol (1990) 0.83
Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr Relat Cancer (2015) 0.82
Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data. Cancer Cytopathol (2014) 0.82
New targeted therapies for anaplastic thyroid cancer. Anticancer Agents Med Chem (2012) 0.81
Anaplastic giant cell thyroid carcinoma. Scand J Surg (2004) 0.81
Evaluation of thyroid incidentaloma. Surg Clin North Am (2014) 0.80
Chemoradiation in anaplastic thyroid carcinomas. Crit Rev Oncol Hematol (2012) 0.77
Long-term survival in young women: hazards and competing risks after thyroid cancer. J Cancer Epidemiol (2012) 0.77
Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature. ScientificWorldJournal (2014) 0.76
Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am (2006) 0.76
Anaplastic thyroid carcinoma arising in long-standing multinodular goiter following radioactive iodine therapy: report of a case diagnosed by fine needle aspiration. Acta Cytol (2009) 0.75
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid (2009) 10.20
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab (2008) 5.94
TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med (2007) 5.92
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell (2003) 5.36
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med (2015) 5.07
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med (2008) 4.39
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med (2010) 4.00
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol (2011) 3.95
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol (2010) 3.75
Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol (2009) 3.73
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol (2013) 3.37
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol (2011) 3.31
Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol (2009) 3.23
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol (2012) 3.18
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol (2010) 2.96
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood (2009) 2.91
Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg (2003) 2.80
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. J Clin Oncol (2009) 2.77
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell (2005) 2.73
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72
Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.71
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers. J Clin Oncol (2011) 2.59
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59
High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg (2003) 2.56
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56
A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid (2008) 2.41
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys (2011) 2.36
The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg (2007) 2.36
Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab (2007) 2.29
Parathyroid cyst: often mistaken for a thyroid cyst. World J Surg (2007) 2.26
Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg (2009) 2.25
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood (2008) 2.24
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood (2008) 2.23
Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development (2004) 2.21
Management of recurrent inguinal hernias. J Am Coll Surg (2009) 2.21
Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med (2010) 2.21
Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A (2009) 2.20
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem (2004) 2.18
The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract (2009) 2.14
Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol (2003) 2.11
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer (2008) 2.09
Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med (2014) 2.09
Human papillomavirus-associated adenocarcinoma of the base of the tongue. Hum Pathol (2013) 2.08
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck (2012) 2.07
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg (2004) 2.05
Small cell lung cancer. J Natl Compr Canc Netw (2013) 2.04
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol (2007) 2.03
TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin (2005) 2.03
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Insulin gene expression is regulated by DNA methylation. PLoS One (2009) 1.97
Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist (2007) 1.96
Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer (2003) 1.94
One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg (2010) 1.94
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid (2009) 1.90
Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab (2011) 1.88
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A (2007) 1.84
The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83
Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol (2013) 1.81
Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet (2012) 1.81
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.80
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab (2012) 1.80
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer (2006) 1.79
Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg (2006) 1.78
Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review. Thyroid (2013) 1.77